Kindly click on the Papers’ link titles below to read more..

Allergies

• Interventional procedure overview of intranasal phototherapy for allergic rhinitis

Immunotherapy

• Safety and Immunological Changes During Sublingual Immunotherapy With Standardized Quality Grass Allergen Tablets

• Sublingual immunotherapy with once-daily grass allergen tablets: A randomized controlled trial in seasonal allergic rhinoconjunctivitis

• Once-daily sublingual allergen-specific immunotherapy improves quality of life in patients with grass pollen-induced allergic rhinoconjunctivitis: A double-blind, randomised study

• Specific Immunotherapy with High Dose SQ Standardized Grass Allergen Tablets was Safe and Well Tolerated

• Prolonged preseasonal treatment phase with Grazax sublingual immunotherapy increases clinical efficacy

• Once Daily Sublingual Immunotherapy without Updosing – A New Treatment Schedule

• Efficacy of sublingual specific immunotherapy in intermittent and persistent allergic rhinitis in children: an observational case-control study on 171 patients. The EFESO-children Multicenter Trial

• Safety of a SQ-standardised grass allergen tablet for sublingual immunotherapy: a randomized, placebo-controlled trial

• Specific immunotherapy with SQ standardized grass allergen tablets in asthmatics with rhinoconjunctivitis

• Shorter Dosing Intervals of Sublingual Immunotherapy Lead to More Efficacious Treatment in a Mouse Model of Allergic Inflammation

• Observational study of sublingual specific immunotherapy in persistent and intermittent allergic rhinitis: the EFESO trial

• Randomized open comparison of the safety of SLIT in a no-updosing and traditional updosing schedule in patients with Parietaria allergy